Possible Consequences for the Pharma Industry if the USP Revision of the General Chapters 41 and 1251 is Enacted

Summary: Expected for a long time, USP has published a new draft to revise the General Chapters 41 “Balances” and 1251 “Weighing on an Analytical Balance” in the Pharmacopeial Forum PF 38(5) on September 4, 2012. One consequence of General Chapter 41 is the so-called